Establishing Reproducible Neuromuscular-on-a-chip Models to Empower Efficacy Predictions
Time: 9:30 am
day: Day 2
Details:
- Showcasing the utilization of neuromuscular models to assess a spectrum of disorders including complement mediated, myotonic dystrophy, or immune-related responses
- Uncovering lessons learned from employing a CIVM to assess for pharmacology and efficacy studies
- Discussing how the efficacy assessments in neuromuscular models contribute to the optimization of candidate treatments, paving the way for enhanced interventions in the field
